Ikarian Capital, LLC - Q3 2022 holdings

$502 Million is the total value of Ikarian Capital, LLC's 104 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 86.1% .

 Value Shares↓ Weighting
RLMD BuyRELMADA THERAPEUTICS INCput$28,703,000
+435.3%
775,300
+174.6%
5.72%
+484.9%
RLMD BuyRELMADA THERAPEUTICS INCcall$28,701,000
+403.7%
775,300
+158.4%
5.72%
+450.4%
SPY NewSPDR S&P 500 ETF TRput$21,431,00060,000
+100.0%
4.27%
SGEN NewSEAGEN INCcall$20,525,000150,000
+100.0%
4.09%
BIIB SellBIOGEN INCcall$18,825,000
-17.7%
70,500
-37.2%
3.75%
-10.1%
AXSM SellAXSOME THERAPEUTICS INCput$18,188,000
-5.0%
407,600
-18.5%
3.62%
+3.8%
ISEE BuyIVERIC BIO INC$17,559,000
+3612.3%
978,783
+1893.5%
3.50%
+3968.6%
NewDICE THERAPEUTICS INCcall$15,188,000748,900
+100.0%
3.03%
ESPR BuyESPERION THERAPEUTICS INC NE$14,278,000
+9.3%
2,131,147
+3.7%
2.84%
+19.4%
BIIB NewBIOGEN INCput$14,204,00053,200
+100.0%
2.83%
RXDX NewPROMETHEUS BIOSCIENCES INC$13,641,000231,181
+100.0%
2.72%
XBI SellSPDR SER TRput$11,898,000
-54.2%
150,000
-57.1%
2.37%
-50.0%
ALT BuyALTIMMUNE INCcall$10,762,000
+202.9%
842,600
+177.5%
2.14%
+231.0%
RXDX NewPROMETHEUS BIOSCIENCES INCcall$10,504,000178,000
+100.0%
2.09%
NewDICE THERAPEUTICS INCput$10,223,000504,100
+100.0%
2.04%
SRPT SellSAREPTA THERAPEUTICS INCcall$9,418,000
+25.7%
85,200
-14.8%
1.88%
+37.3%
DCPH NewDECIPHERA PHARMACEUTICALS IN$9,107,000492,275
+100.0%
1.82%
BLU SellBELLUS HEALTH INC NEW$8,977,000
-4.6%
850,134
-16.5%
1.79%
+4.3%
CLDX SellCELLDEX THERAPEUTICS INC NEW$8,924,000
-38.5%
317,476
-41.0%
1.78%
-32.8%
MIST SellMILESTONE PHARMACEUTICALS IN$7,863,000
-4.0%
855,616
-38.0%
1.57%
+4.9%
ISEE BuyIVERIC BIO INCcall$7,856,000
+234.2%
437,900
+79.2%
1.56%
+264.8%
TCDA BuyTRICIDA INCput$7,628,000
+748.5%
727,900
+683.5%
1.52%
+826.8%
GOSS SellGOSSAMER BIO INC$7,313,000
-12.7%
610,407
-39.0%
1.46%
-4.6%
SellAMYLYX PHARMACEUTICALS INCcall$7,037,000
+4.1%
250,000
-28.7%
1.40%
+13.8%
KRYS NewKRYSTAL BIOTECH INCput$6,635,00095,200
+100.0%
1.32%
BuyASTRIA THERAPEUTICS INC$6,322,000
+256.0%
699,440
+18.1%
1.26%
+288.9%
GOSS BuyGOSSAMER BIO INCcall$6,308,000
+125.3%
526,600
+57.4%
1.26%
+146.0%
KZR SellKEZAR LIFE SCIENCES INC$6,273,000
-46.1%
728,586
-48.3%
1.25%
-41.1%
SAGE NewSAGE THERAPEUTICS INC$6,180,000157,805
+100.0%
1.23%
TCDA NewTRICIDA INCcall$6,054,000577,600
+100.0%
1.21%
ALT SellALTIMMUNE INC$6,028,000
-42.6%
472,054
-47.4%
1.20%
-37.3%
XENE SellXENON PHARMACEUTICALS INC$5,794,000
-20.4%
160,486
-33.0%
1.16%
-13.0%
TERN BuyTERNS PHARMACEUTICALS INC$5,326,000
+206.8%
904,119
+29.2%
1.06%
+234.7%
ACAD NewACADIA PHARMACEUTICALS INC$5,317,000325,000
+100.0%
1.06%
HZNP SellHORIZON THERAPEUTICS PUB Lcall$5,267,000
-34.0%
85,100
-14.9%
1.05%
-27.8%
CERE NewCEREVEL THERAPEUTICS HLDNG I$5,033,000178,100
+100.0%
1.00%
STOK NewSTOKE THERAPEUTICS INCput$4,734,000368,700
+100.0%
0.94%
TCON SellTRACON PHARMACEUTICALS INC$4,618,000
-17.2%
2,765,530
-0.8%
0.92%
-9.5%
HZNP SellHORIZON THERAPEUTICS PUB L$4,593,000
-64.0%
74,219
-53.6%
0.92%
-60.7%
IMVT NewIMMUNOVANT INC$4,529,000811,700
+100.0%
0.90%
ARVN NewARVINAS INCcall$4,450,000100,000
+100.0%
0.89%
PRTA NewPROTHENA CORP PLCcall$4,050,00066,800
+100.0%
0.81%
ARDX BuyARDELYX INC$3,784,000
+281.8%
3,178,825
+89.2%
0.75%
+316.6%
ABOS NewACUMEN PHARMACEUTICALS INC$3,511,000350,000
+100.0%
0.70%
PNT NewPOINT BIOPHARMA GLOBAL INC$3,482,000450,406
+100.0%
0.69%
RETA SellREATA PHARMACEUTICALS INCcall$3,470,000
-29.5%
138,100
-14.8%
0.69%
-23.1%
AVTE NewAEROVATE THERAPEUTICS INC$3,316,000200,000
+100.0%
0.66%
ARKG NewARK ETF TRgenomic rev etf$3,171,00096,462
+100.0%
0.63%
SCPH SellSCPHARMACEUTICALS INC$3,126,000
-26.6%
479,383
-45.8%
0.62%
-19.8%
MIST NewMILESTONE PHARMACEUTICALS INput$3,107,000338,000
+100.0%
0.62%
BLUE NewBLUEBIRD BIO INC$2,928,000462,628
+100.0%
0.58%
BIIB BuyBIOGEN INC$2,926,000
+1183.3%
10,962
+877.0%
0.58%
+1288.1%
RVNC NewREVANCE THERAPEUTICS INC$2,700,000100,000
+100.0%
0.54%
COGT SellCOGENT BIOSCIENCES INC$2,429,000
+7.7%
162,766
-34.9%
0.48%
+17.8%
STSA NewSATSUMA PHARMACEUTICALS INCcall$2,400,000400,000
+100.0%
0.48%
DCPH NewDECIPHERA PHARMACEUTICALS INcall$2,268,000122,600
+100.0%
0.45%
INSM NewINSMED INCcall$2,154,000100,000
+100.0%
0.43%
SRPT SellSAREPTA THERAPEUTICS INC$1,858,000
-0.9%
16,809
-32.8%
0.37%
+8.2%
LYRA SellLYRA THERAPEUTICS INC$1,722,000
-12.3%
343,685
-1.1%
0.34%
-4.2%
MIST SellMILESTONE PHARMACEUTICALS INcall$1,657,000
+31.4%
180,300
-15.1%
0.33%
+43.5%
NewCINCOR PHARMA INC$1,481,00045,100
+100.0%
0.30%
AKRO NewAKERO THERAPEUTICS INCcall$1,392,00040,900
+100.0%
0.28%
ESPR NewESPERION THERAPEUTICS INC NEcall$1,339,000200,000
+100.0%
0.27%
VKTX SellVIKING THERAPEUTICS INC$1,260,000
-47.8%
463,156
-44.6%
0.25%
-43.0%
ICPT SellINTERCEPT PHARMACEUTICALS IN$1,189,000
-17.9%
85,200
-18.9%
0.24%
-10.2%
GERN NewGERON CORPcall$1,170,000500,000
+100.0%
0.23%
ETNB New89BIO INC$1,158,000200,000
+100.0%
0.23%
OCUL NewOCULAR THERAPEUTIX INC$1,099,000265,000
+100.0%
0.22%
XFOR SellX4 PHARMACEUTICALS INC$973,000
-40.0%
568,612
-66.1%
0.19%
-34.5%
CLNN NewCLENE INCcall$903,000322,600
+100.0%
0.18%
BLU SellBELLUS HEALTH INC NEWcall$900,000
-2.6%
85,200
-14.8%
0.18%
+6.5%
MCRB SellSERES THERAPEUTICS INC$843,000
-54.5%
131,310
-75.7%
0.17%
-50.3%
BCLI SellBRAINSTORM CELL THERAPEUTICS$839,000
+20.2%
189,935
-25.1%
0.17%
+31.5%
DSGN NewDESIGN THERAPEUTICS INCput$811,00048,500
+100.0%
0.16%
STSA SellSATSUMA PHARMACEUTICALS INC$815,000
-69.9%
136,059
-79.2%
0.16%
-67.1%
SellRENOVACOR INC$725,000
+21.8%
288,119
-1.8%
0.14%
+33.3%
ELDN SellELEDON PHARMACEUTICALS INC$612,000
-30.8%
221,830
-38.8%
0.12%
-24.2%
CMMB SellCHEMOMAB THERAPEUTICS LTDsponsored ads$612,000
-38.3%
245,896
-8.3%
0.12%
-32.6%
ALNY SellALNYLAM PHARMACEUTICALS INC$560,000
-93.7%
2,800
-95.4%
0.11%
-93.1%
AUTL SellAUTOLUS THERAPEUTICS PLCspon ads$556,000
-39.0%
260,087
-19.3%
0.11%
-33.1%
TARA SellPROTARA THERAPEUTICS INC$558,000
-26.2%
188,664
-26.8%
0.11%
-19.6%
SellBELLICUM PHARMACEUTICALS INC$537,000
-13.0%
448,101
-14.4%
0.11%
-5.3%
RPHM SellRENEO PHARMACEUTICALS INC$521,000
+6.1%
155,819
-16.0%
0.10%
+15.6%
CLNN NewCLENE INCput$496,000177,400
+100.0%
0.10%
IMTX SellIMMATICS N.V$490,000
-64.2%
49,031
-68.8%
0.10%
-60.8%
RETA NewREATA PHARMACEUTICALS INCput$463,00018,400
+100.0%
0.09%
ANEB SellANEBULO PHARMACEUTICALS INC$437,000
-53.6%
156,203
-13.8%
0.09%
-49.4%
CLVS SellCLOVIS ONCOLOGY INC$430,000
-43.5%
361,518
-14.4%
0.09%
-38.1%
FNCH SellFINCH THERAPEUTICS GROUP INC$397,000
-57.7%
237,553
-28.1%
0.08%
-53.8%
SYBX SellSYNLOGIC INC$292,000
-46.4%
306,757
-35.3%
0.06%
-41.4%
CNTB SellCONNECT BIOPHARMA HLDGS LTDads$283,000
-52.1%
219,501
-67.6%
0.06%
-48.1%
GOSS NewGOSSAMER BIO INCput$209,00017,400
+100.0%
0.04%
VRNA BuyVERONA PHARMA PLCsponsored ads$193,000
-3.5%
315,131
+5.0%
0.04%
+5.6%
ARKK NewARK ETF TRinnovation etf$171,0004,519
+100.0%
0.03%
PRAX SellPRAXIS PRECISION MEDICINES Icall$168,000
-36.1%
74,200
-30.8%
0.03%
-31.2%
ASLN SellASLAN PHARMACEUTICALS LTDads$146,000
-21.1%
820,455
-15.5%
0.03%
-14.7%
MITO SellSTEALTH BIOTHERAPEUTICS CORPsponsored ads$134,000
+5.5%
435,516
-13.2%
0.03%
+17.4%
CABA SellCABALETTA BIO INC$109,000
-89.1%
168,623
-82.1%
0.02%
-87.9%
RETA SellREATA PHARMACEUTICALS INCcl a$102,000
-83.9%
4,064
-80.5%
0.02%
-82.6%
SPPI NewSPECTRUM PHARMACEUTICALS INC$76,000176,980
+100.0%
0.02%
CRBP SellCORBUS PHARMACEUTICALS HLDGS$66,000
-69.6%
397,168
-54.0%
0.01%
-67.5%
IVA SellINVENTIVA SAads$48,000
-48.4%
13,236
-15.0%
0.01%
-41.2%
OTIC ExitOTONOMY INC$0-180
-100.0%
0.00%
ERYP NewERYTECH PHARMAsponsored adr$2,0003,019
+100.0%
0.00%
KDNY SellCHINOOK THERAPEUTICS INC$0283,464
-14.7%
0.00%
ExitBAUDAX BIO INC$0-2,966
-100.0%
-0.00%
ExitALTAMIRA THERAPEUTICS LTD$0-75,000
-100.0%
-0.01%
ENVB ExitENVERIC BIOSCIENCES INC$0-223,834
-100.0%
-0.01%
OVID ExitOVID THERAPEUTICS INC$0-26,831
-100.0%
-0.01%
MNMD ExitMIND MEDICINE MINDMED INC$0-105,958
-100.0%
-0.01%
ExitBRIGHT MINDS BIOSCIENCES INC$0-105,958
-100.0%
-0.02%
LRMR ExitLARIMAR THERAPEUTICS INC$0-51,606
-100.0%
-0.02%
CYCC ExitCYCLACEL PHARMACEUTICALS INC$0-104,741
-100.0%
-0.02%
TPST ExitTEMPEST THERAPEUTICS INC$0-61,827
-100.0%
-0.02%
MBIO ExitMUSTANG BIO INC$0-246,824
-100.0%
-0.03%
CLNN ExitCLENE INC$0-70,000
-100.0%
-0.03%
ExitMYMD PHARMACEUTICALS INC$0-81,089
-100.0%
-0.03%
YMTX ExitYUMANITY THERAPEUTICS INC$0-104,392
-100.0%
-0.04%
MREO ExitMEREO BIOPHARMA GROUP PLCads$0-615,856
-100.0%
-0.04%
IMUX ExitIMMUNIC INC$0-61,500
-100.0%
-0.04%
IMUX ExitIMMUNIC INCput$0-61,500
-100.0%
-0.04%
ExitREGULUS THERAPEUTICS INC$0-105,341
-100.0%
-0.04%
HEPA ExitHEPION PHARMACEUTICALS INC$0-410,189
-100.0%
-0.04%
IPA ExitIMMUNOPRECISE ANTIBODIES LTD$0-61,433
-100.0%
-0.04%
VSTM ExitVERASTEM INC$0-228,023
-100.0%
-0.05%
ZLAB ExitZAI LAB LTDadr$0-81,843
-100.0%
-0.05%
WVE ExitWAVE LIFE SCIENCES LTD$0-98,039
-100.0%
-0.06%
NXTC ExitNEXTCURE INC$0-71,435
-100.0%
-0.06%
ExitCASI PHARMACEUTICALS INC$0-132,014
-100.0%
-0.07%
EOLS ExitEVOLUS INC$0-45,516
-100.0%
-0.10%
INBX ExitINHIBRX INC$0-49,372
-100.0%
-0.10%
RCUS ExitARCUS BIOSCIENCES INCcall$0-23,200
-100.0%
-0.11%
ATHA ExitATHIRA PHARMA INCput$0-199,500
-100.0%
-0.11%
CFRX ExitCONTRAFECT CORPput$0-200,000
-100.0%
-0.11%
SNPX ExitSYNAPTOGENIX INC$0-121,191
-100.0%
-0.11%
ExitPARDES BIOSCIENCES INC$0-223,934
-100.0%
-0.12%
ALRN ExitAILERON THERAPEUTICS INC$0-2,892,316
-100.0%
-0.14%
GMTX ExitGEMINI THERAPEUTICS INC$0-443,096
-100.0%
-0.14%
AYLA ExitAYALA PHARMACEUTICALS INC$0-697,316
-100.0%
-0.14%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-702,773
-100.0%
-0.14%
FULC ExitFULCRUM THERAPEUTICS INCcall$0-182,200
-100.0%
-0.16%
CMRX ExitCHIMERIX INC$0-441,203
-100.0%
-0.17%
MRUS ExitMERUS N V$0-53,703
-100.0%
-0.22%
RCUS ExitARCUS BIOSCIENCES INCput$0-50,000
-100.0%
-0.23%
ExitAADI BIOSCIENCE INC$0-412,343
-100.0%
-0.23%
VBLT ExitVASCULAR BIOGENICS LTD$0-830,007
-100.0%
-0.24%
DBVT ExitDBV TECHNOLOGIES S Asponsored adr$0-316,939
-100.0%
-0.26%
ALDX ExitALDEYRA THERAPEUTICS INC$0-375,000
-100.0%
-0.27%
BBIO ExitBRIDGEBIO PHARMA INCcall$0-200,000
-100.0%
-0.33%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-41,900
-100.0%
-0.34%
ITOS ExitITEOS THERAPEUTICS INCcall$0-100,000
-100.0%
-0.38%
ACET ExitADICET BIO INC$0-143,214
-100.0%
-0.38%
ATHA ExitATHIRA PHARMA INCcall$0-784,200
-100.0%
-0.44%
INSM ExitINSMED INC$0-125,000
-100.0%
-0.45%
BPMC ExitBLUEPRINT MEDICINES CORPcall$0-64,000
-100.0%
-0.59%
KWEB ExitKRANESHARES TRcsi chi internet$0-100,000
-100.0%
-0.60%
VRDN ExitVIRIDIAN THERAPEUTICS INCcall$0-300,000
-100.0%
-0.63%
NBIX ExitNEUROCRINE BIOSCIENCES INC$0-38,600
-100.0%
-0.69%
PFE ExitPFIZER INC$0-80,000
-100.0%
-0.76%
HRMY ExitHARMONY BIOSCIENCES HLDGS IN$0-86,035
-100.0%
-0.76%
ExitAMYLYX PHARMACEUTICALS INC$0-246,554
-100.0%
-0.87%
GLPG ExitGALAPAGOS NVspon adr$0-86,865
-100.0%
-0.88%
ICPT ExitINTERCEPT PHARMACEUTICALS INcall$0-350,000
-100.0%
-0.88%
PCVX ExitVAXCYTE INC$0-225,991
-100.0%
-0.90%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-60,000
-100.0%
-0.91%
APLS ExitAPELLIS PHARMACEUTICALS INCcall$0-123,200
-100.0%
-1.02%
ALNY ExitALNYLAM PHARMACEUTICALS INCput$0-39,900
-100.0%
-1.06%
LNTH ExitLANTHEUS HLDGS INCcall$0-100,000
-100.0%
-1.20%
SAGE ExitSAGE THERAPEUTICS INCcall$0-250,000
-100.0%
-1.47%
BMRN ExitBIOMARIN PHARMACEUTICAL INCcall$0-106,700
-100.0%
-1.61%
KZR ExitKEZAR LIFE SCIENCES INCcall$0-1,075,300
-100.0%
-1.62%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-40,000
-100.0%
-1.72%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-40,000
-100.0%
-2.06%
KRTX ExitKARUNA THERAPEUTICS INCput$0-100,000
-100.0%
-2.31%
KRTX ExitKARUNA THERAPEUTICS INC$0-100,000
-100.0%
-2.31%
AXSM ExitAXSOME THERAPEUTICS INCcall$0-350,000
-100.0%
-2.44%
CLDX ExitCELLDEX THERAPEUTICS INC NEWcall$0-506,500
-100.0%
-2.49%
CLDX ExitCELLDEX THERAPEUTICS INC NEWput$0-616,700
-100.0%
-3.03%
AMGN ExitAMGEN INCcall$0-100,000
-100.0%
-4.44%
ALNY ExitALNYLAM PHARMACEUTICALS INCcall$0-291,300
-100.0%
-7.75%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XENON PHARMACEUTICALS INC15Q2 20231.5%
OCULAR THERAPEUTIX INC15Q3 20231.4%
SAREPTA THERAPEUTICS INC14Q3 20236.4%
X4 PHARMACEUTICALS INC - PIPE14Q2 20231.4%
PROTARA THERAPEUTICS INC14Q3 20231.2%
SPDR SER TR13Q3 20239.0%
VAXCYTE INC13Q3 20232.9%
TRACON PHARMACEUTICALS INC13Q3 20231.4%
MILESTONE PHARMACEUTICALS IN13Q3 20231.7%
BELLUS HEALTH INC NEW13Q1 20231.8%

View Ikarian Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

View Ikarian Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-05
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View Ikarian Capital, LLC's complete filings history.

Compare quarters

Export Ikarian Capital, LLC's holdings